Brief: Paratek Pharmaceuticals Acknowledges Receipt Of Nexpoint Letter
27/06/2023 19:03
June 27 (Reuters) - Paratek Pharmaceuticals Inc
PRTK.O :
* PARATEK PHARMACEUTICALS ACKNOWLEDGES RECEIPT OF NEXPOINT
LETTER
* PARATEK PHARMACEUTICALS INC - BOARD "DISAGREES" WITH
NEXPOINT'S
CHARACTERIZATIONS CONTAINED IN ITS LETTER
Source text for Eikon: ID:nGNXbC5knX
Further company coverage: PRTK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paratek Pharmaceuticals
See all newsNovo Holdings closes $462 mln acquisition of Paratek Pharmaceuticals
Brief: Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Responds to Demand Letters From 11 Stockholders Alleging 'Misleading', Incomplete Statements In Proxy Statement Filed On June 30
Brief: Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Announces Second Quarter 2023 Revenue Of $40.0 Million